Provided by Tiger Trade Technology Pte. Ltd.

Pros

23.25
0.0000
Volume:- -
Turnover:- -
Market Cap:1.12B
PE:-78.05
High:23.25
Open:23.25
Low:23.25
Close:23.25
52wk High:23.26
52wk Low:13.61
Shares:48.30M
Float Shares:40.22M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2979
EPS(LYR):-0.4346
ROE:-28896.55%
ROA:-2.39%
PB:-14.74
PE(LYR):-53.50

Loading ...

Baidu Announces Launch of AI Glasses PRO at 2299 Yuan

Deep News
·
Nov 13, 2025

Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO® to Australia and New Zealand

GlobeNewswire
·
Nov 12, 2025

PRO REIT Q3 FFO $0.12 Up From $0.11 YoY, Sales $27.102M Up From $24.033M YoY

Benzinga
·
Nov 12, 2025

Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO® and Sonalleve® with Al Faisaliah Medical Systems in Saudi Arabia

GlobeNewswire
·
Nov 12, 2025

Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO® in Canada from Knight

GlobeNewswire
·
Nov 11, 2025

AI Isn't the Only Investing Game in Town. 5 Under-the-Radar Ideas From Money Pros. -- Barrons.com

Dow Jones
·
Nov 06, 2025

Prophecy International Holdings Limited (ASX:PRO) Not Doing Enough For Some Investors As Its Shares Slump 26%

Simply Wall St.
·
Oct 30, 2025

PROS Holdings Faces Uncertainty and Financial Risks Amid Proposed Merger Challenges

TIPRANKS
·
Oct 29, 2025

Pros Holdings Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Oct 28, 2025

BRIEF-PROS Holdings, Inc. Reports Third Quarter 2025 Financial Results

Reuters
·
Oct 28, 2025

PROS Holdings Q3 revenue beats estimates on subscription growth

Reuters
·
Oct 28, 2025

PROS Holdings Inc. reports Q3 revenue of $91.7 million

Reuters
·
Oct 28, 2025

BRIEF-PROS Holdings Q3 Adjusted EPS USD 0.22 Vs. IBES Estimate USD 0.16

Reuters
·
Oct 28, 2025

Pros Holdings Q3 Subscription Gross Margin 69%

THOMSON REUTERS
·
Oct 28, 2025

Corrected- Pros Holdings Q3 Gross Margin 69% (Removes Extraneous Word 'Subscription')

THOMSON REUTERS
·
Oct 28, 2025

Pros Holdings Q3 EPS USD -0.09

THOMSON REUTERS
·
Oct 28, 2025

PROS Holdings Inc. Announces Date for Special Stockholders Meeting

Reuters
·
Oct 23, 2025

PROS Holdings Launches AI-Powered Pricing Solution on SAP Store

Reuters
·
Oct 21, 2025

SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology

GlobeNewswire
·
Oct 21, 2025

SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology

GlobeNewswire
·
Oct 21, 2025